SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-106936
Filing Date
2022-10-07
Accepted
2022-10-07 08:20:15
Documents
13
Period of Report
2022-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2227789d1_8k.htm   iXBRL 8-K 35179
2 EXHIBIT 99.1 tm2227789d1_ex99-1.htm EX-99.1 12264
  Complete submission text file 0001104659-22-106936.txt   227168

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA repl-20221006.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20221006_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20221006_pre.xml EX-101.PRE 22597
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2227789d1_8k_htm.xml XML 3597
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 221299339
SIC: 2836 Biological Products, (No Diagnostic Substances)